LAUREN VOLPE: Open Payments
NPI 1235790486 · EAST GREENWICH, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,450 in 114 payments from 10 companies in 2025. Trend: 2023 $1,665 · 2024 $1,611 · 2025 $1,450
Food & beverage: $1,342Education: $109
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 50 | $669 |
| ABBVIE INC. | 32 | $292 |
| Arcutis Biotherapeutics, Inc. | 17 | $224 |
| LEO Pharma Inc. | 5 | $104 |
| Amgen Inc. | 4 | $67 |
| Novartis Pharmaceuticals Corporation | 2 | $39 |
| Galderma Laboratories, L.P. | 1 | $19 |
| REVANCE THERAPEUTICS, INC. | 1 | $14 |
| E.R. Squibb & Sons, L.L.C. | 1 | $14 |
| Organon LLC | 1 | $10 |
Products named: TREMFYA, Zoryve, RINVOQ, SKYRIZI, OTEZLA, ADBRY, ANZUPGO, COSENTYX.
Industry payments across RI — which companies pay providers there.
